The anti-hypertensive drug, Nilvadipine, has been shown to enhance Aβ clearance, decrease tau phosphorylation, and reduce inflammation in a mouse model of AD (Paris et al., 2014). The gene discussed is MAPT; the disease is Alzheimer disease.